The invention relates to pharmaceutical compounds which are based on the anti-inflammatory properties of etheric oils selected from the group consisting of Origanum vulgaris, Thymus vulgaris, Mentha piperita, Thymus serpilum, Saturea hortensis, Saturea montana, Saturea subricata, Carum corticum, Thymus zugis, Ocimum gratisimum, Moranda pungtata, Mosla japanoica and Salvia officinalis. Preferably the etheric oils, obtained at the distillation of Origanum vulgaris, Thymus vulgaris and/or Mentha piperita are used. Such pharmaceutical compounds, compared to synthetic sulfonamids, antibiotics and cortisones do not create biorecidives in the human body as well as in animal meat and milk and do not contribute to the resistance of microorganism against pharmaceutical compositions in general. The composition according to the invention can be used in the treatment of colibacillosis, dermatomycosis, lice, perspiration and fungus on feet, dermatitis, acne and of veterinary diseases like coccidiosis, mastitis, etc.
展开▼
